Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U6atac small nuclear 40, pseudogene (RNU6ATAC40P) is a non-coding RNA classified as a pseudogene, presumed to originate from the U6atac snRNA gene family but lacking protein-coding or canonical functional capacity[1]. U6atac snRNA itself is a component of the minor spliceosome, essential for the splicing of a subset of introns in eukaryotic pre-mRNA, but RNU6ATAC40P, as a pseudogene, typically does not produce a functional RNA product[1][3]. Some pseudogenes can exert regulatory effects at the RNA level in certain contexts, such as acting as competing endogenous RNAs (ceRNAs) or being sources of small RNAs, but this has not been specifically demonstrated for RNU6ATAC40P[2][4]. RNU6ATAC40P is not recognized as a therapeutic or druggable target, nor is it directly implicated in any disease processes or clinical applications[1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6atac small nuclear 40, pseudogene (RNU6ATAC40P).